Baseline laboratory panel: difference between revisions
Diff·revision 11 → 12·15:11, 9 Mar 2025
Difference between revision 11 and revision 12 of Baseline laboratory panel. 5 lines changed; the page grew by 74 bytes.
| Revision 11 — 09:22, 17 Feb 2025 DEXA_Dilys (talk) alphabetise the see-also list 2,965 bytes +592 | Revision 12 — 15:11, 9 Mar 2025 CategoryBot (talk) bot: add stub category 3,039 bytes +74 | ||
|---|---|---|---|
| 37 | <ref name="wallace2004">Wallace TM, Levy JC, Matthews DR. "Use and abuse of HOMA modeling." ''Diabetes Care'' 27(6):1487–1495 (2004). PMID 15161807.</ref> | 37 | <ref name="wallace2004">Wallace TM, Levy JC, Matthews DR. "Use and abuse of HOMA modeling." ''Diabetes Care'' 27(6):1487–1495 (2004). PMID 15161807.</ref> |
| 38 | 38 | ||
| + | 39 | == See also == | |
| + | 40 | * [[Haemoglobin A1c]] | |
| + | 41 | * [[Fasting insulin]] | |
| + | 42 | * [[HOMA-IR]] | |
| + | 43 | ||
| 39 | {{DEFAULTSORT:Baseline laboratory panel}} | 44 | {{DEFAULTSORT:Baseline laboratory panel}} |
| 40 | [[Category:Metabolic biomarkers]] | 45 | [[Category:Metabolic biomarkers]] |